Going concern
Filing comparison
LIXTE BIOTECHNOLOGY HOLDINGS, INC. no longer discloses a going-concern conclusion
Substantial doubt about ability to continue as a going concern → No going-concern disclosure
… scale back, or eliminate its clinical development programs; curtail expenditures related to the LiGHT system; or pursue strategic alternatives, including potential asset sales or the cessation of operations. - 58 - As a result, management has concluded, and our independent registered public accounting firm has agreed with our conclusion, that there is a substantial doubt regarding the Company’s ability to continue as a going concern for a period of at least 12 months beyond the filing of this Annual Report on Form 10-K. As a result, the report of our independent registered public accounting…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- none
- Current state label
- No going-concern disclosure
- Direction
- eased
- Located in
- going-concern note
- Prior filed
- 2025-03-24
- Prior form
- 10-K
- Prior state
- substantial_doubt
- Prior state label
- Substantial doubt about ability to continue as a going concern
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.